Skip to main content
Publication date
2016 10
Authors
Zignol, M Dean, AS Alikhanova, N Andres, S Cabibbe, AM Cirillo, DM Dadu, A Dreyer, A Driesen, M Gilpin, C Hasan, R Hasan, Z Hoffner, S Husain, A Hussain, A Ismail, N Kamal, M Mansjo, M Mvusi, L Niemann, S Omar, SV Qadeer, E Rigouts, L Ruesch-Gerdes, S Schito, M Seyfaddinova, M Skrahina, A Tahseen, S Wells, WA Mukadi, YD Kimerling, M Floyd, K Weyer, K Raviglione, MC
Author KI Usernames
Hoffner, S|svhoff
Pubmed ID
27397590
Journal
The Lancet. Infectious diseases
Doctype
Article
KI Connection
Låg
Mesh SV
Antiinfektiva medel Antituberkulosmedel Asien Befolkningsstudier Fluorokinoloner Lungtuberkulos Mikrobiologisk resistensbestämning Mycobacterium tuberculosis Människa Pyrazinamid Retrospektiva studier Rifampin Sydafrika Tuberkulos, läkemedelsresistent
Mesh EN
Anti-Infective Agents Antitubercular Agents Asia Fluoroquinolones Microbial Sensitivity Tests Mycobacterium tuberculosis Population Surveillance Pyrazinamide Retrospective Studies Rifampin South Africa Tuberculosis, Multidrug-Resistant Tuberculosis, Pulmonary
First date
2016-10-02T10:52:57.887Z